SUPPORT OUR JOURNALISM: Please consider donating to keep our website running and free for all - thank you!

Spain

Queen Sofía marks World Alzheimer’s Day with focus on research

Queen Sofía of Spain has marked World Alzheimers Day by attending the opening of the International Congress for Investigation and Innovation on Neurodegenerative Diseases. 

The event was held at the Alzheimer Centre of the Reina Sofía Foundation in Madrid on Tuesday, the 21st of September 2021. Also in attendance were Spain’s Health Secretary, Silvia Calzón, the Secretary General of Research, Raquel Yotti, the Minister for Family, Youth and Social Policy of the Madrid Community, Concepción Dancausa and the Director of the Carlos III Health Institute, Cristóbal Belda. 

All of them, along with Queen Sofía, spoke at the event. All of them agreed on the importance of technological advances for research purposes, as well as the key role education plays in raising a new generations of doctors, scientists, developers and researchers. 

The roundtable was organised by the Reina Sofía Foundation, the CIEN Foundation (a research centre on neurologic diseases), the CIBERNED (a centre of online research for neurodegenerative diseases) and the Council for Family, Youth and Social Policy of the Autonomic Community of Madrid. 

The event continues until 22nd of September with only those speaking attending the event in person to maintain social distancing.The event is also accessible via streaming. 

This Congress will focus on discussing the progress made on research and technological developments for treatment and management of Alzheimer’s, Parkinson’s, Huntington’s and other neurological and neurodegenerative diseases. 

This entire conference is also a part of NEURO 2020/22, an entire year dedicated to tackling research on the causes of neurodegenerative diseases, which are the only way of developing cures that will, eventually, reduce the number of people affected by such illnesses. 

Queen Sofía has long been engaged in the health sector, focussing specifically on neurological and neurodegenerative diseases.